Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v6-FR Version v4-FR
Language French French
Date Updated 2018-08-01 2018-07-03
Drug Identification Number 02258331 02258331
Brand name MYLAN-CLINDAMYCIN MYLAN-CLINDAMYCIN
Common or Proper name CLINDAMYCIN CLINDAMYCIN
Company Name MYLAN PHARMACEUTICALS ULC MYLAN PHARMACEUTICALS ULC
Ingredients CLINDAMYCIN CLINDAMYCIN
Strength(s) 150MG 150MG
Dosage form(s) CAPSULE CAPSULE
Route of administration ORAL ORAL
Packaging size 100 BT 100 BT
ATC code J01FF J01FF
ATC description MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS
Reason for discontinuation Business reasons Business reasons
Anticipated discontinuation date 2018-07-03 2018-07-03
Actual discontinuation date 2018-07-03
Remaining supply date 2018-07-03 2018-07-03
Discontinuation status Discontinued To be discontinued
Discontinuation decision reversal no no
Tier 3 Status No No
Information on remaining supply
Company comments Discontinued in shortage ID 9036. Last Lot # 3088790 Expires 31-Aug-22 Discontinued in shortage ID 9036. Last Lot # 3088790 Expires 31-Aug-22
Health Canada comments